Tag Archives: HIVE

Top 10 Tech Stocks To Own Right Now

Warren Buffett attends the world premiere screening of HBO’s “Becoming Warren Buffett” at The Museum of Modern Art on Thursday, Jan. 19, 2017, in New York. (Photo by Charles Sykes/Invision/AP)

Warren Buffett rarely likes technology stocks.

His rationale? Stick with what you know. Buffett readily admits that he does not understand technology so he has avoided investments in the technology sector.

Over the years, there have been exceptions to this rule – including Buffett’s investments in IBM and Microsoft, among others.

Perhaps chief among these exceptions is Buffett’s investment in Apple. Over the past year, Buffett, through his holding company, Berkshire Hathaway, has amassed more than 61 million shares in Apple, making Berkshire a top 10 Apple shareholder with its 1% stake.

Top 10 Tech Stocks To Own Right Now: Broadcom Corporation(BRCM)

Advisors’ Opinion:

  • [By Max Byerly]

    Headlines about Broadcom (NASDAQ:BRCM) have trended somewhat positive this week, according to Accern Sentiment. The research firm scores the sentiment of media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Broadcom earned a news impact score of 0.16 on Accern’s scale. Accern also gave media headlines about the semiconductor manufacturer an impact score of 43.7335359332371 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Paul Ausick]

    Broadcom Inc. (NASDAQ: BRCM) traded down about 1.4% Friday and posted a new 52-week low of $222.00 after closing Thursday at $225.25. The stock’s 52-week high is $285.68. Volume totaled around 3.9 million, just under the daily average of about 4.1 million. The company had no specific news.

Top 10 Tech Stocks To Own Right Now: Ambarella, Inc.(AMBA)

Advisors’ Opinion:

  • [By Chris Lange]

    Ambarella Inc. (NASDAQ: AMBA) is scheduled to report its fiscal fourth-quarter results after trading closes on Tuesday. The consensus estimates call for EPS of $0.04 and $51.08 million in revenue. Shares were changing hands at $40.02 on Friday’s close. The consensus price target is $44.56, and the 52-week trading range is $30.00 to $55.50.

  • [By Garrett Baldwin]

    Starbuck’s Corp. (Nasdaq: SBUX) Executive Chair Howard Schultz announced he will depart the company. Many are speculating he will pursue a career in politics and potentially seek the Democratic nomination for president in 2020. Schultz had previously denied any speculation around a role in government; but his recent comments suggest that “public service” will be a part of his future plans. Gold prices dipped below $1,300 per ounce as markets continue to speculate on the likelihood of additional interest rate hikes in 2018. We believe this is solid buying opportunity for investors. The reason why gold is going to get a nice boost: ongoing trade tensions between the United States and the rest of the globe. Money Morning Resource Specialist Peter Krauth provides his insight on where gold prices are heading next and how you can make big gains in the weeks ahead.
    Three Stocks to Watch Today: AAPL, TWTR, SCGLF
    Apple Inc. (Nasdaq: AAPL) is on the verge of becoming the world’s first $1 trillion company. The stock pushed above $192.60 per share in pre-market hours after its first day at the Worldwide Developers Conference. During the event, the company unveiled its new mobile operating system, called iOS 12. The firm also unveiled a suite of tools designed to combat technology addiction. Shares of Twitter Inc. (NYSE: TWTR) jumped nearly 4% on news that the social media company is about to join the S&P 500. The company will join on Thursday morning and will replace agribusiness giant Monsanto Co. (NYSE: MON). The news comes as Monsanto is in the final steps of its merger with German chemical giant Bayer AG (Nasdaq: BAYRY). Shares of Societe Generale SA (ADR) (OTCMKTS: SCGLF) are in focus after the U.S. Justice Department announced the French investment bank will pay $1.3 billion to settle two ongoing legal headaches. The company bribed Libyan officials and manipulated LIBOR, a benchmark interest rate on which most financing is based. Legg Mason Inc. (NYSE: L

  • [By Nicholas Rossolillo]

    Video chip maker Ambarella’s (NASDAQ:AMBA) claim to fame was making crucial hardware for action camera company GoPro. That main business has been in decline, though, leaving Ambarella shareholders with a stock that has been stuck in a rut the last few years. However, a new technology — computer vision — has management optimistic that a new revenue source is in the works.

  • [By Nicholas Rossolillo]

    Shares of video processing and computer vision chip maker Ambarella (NASDAQ:AMBA) rallied after the company reported results for its fiscal year 2019 fourth quarter (the year ended January 31, 2019). The stock’s rise should give long-suffering shareholders reason to breathe a little easier after a bruising year. Shares were down 25% from the beginning of 2018 through the day of the report on March 5, 2019.

Top 10 Tech Stocks To Own Right Now: Silicon Graphics International Corp(SGI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Superior Gold (CVE:SGI) will be releasing its earnings data before the market opens on Tuesday, August 21st. Analysts expect Superior Gold to post earnings of C$0.05 per share for the quarter.

Top 10 Tech Stocks To Own Right Now: GRAVITY Co. Ltd.(GRVY)

Advisors’ Opinion:

  • [By Cooper Creagan]

    For example, if you had taken five minutes to set up a Night Trade on Gravity Co. (Nasdaq: GRVY) in October, you could’ve tripled your money, and then some.

  • [By Joseph Griffin]

    BidaskClub upgraded shares of Gravity (NASDAQ:GRVY) from a strong sell rating to a sell rating in a research note issued to investors on Tuesday morning.

  • [By Max Byerly]

    ILLEGAL ACTIVITY WARNING: “Gravity (GRVY) Receives Coverage Optimism Score of 0.17” was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at www.tickerreport.com/banking-finance/3382037/gravity-grvy-receives-coverage-optimism-score-of-0-17.html.

Top 10 Tech Stocks To Own Right Now: Sify Technologies Limited(SIFY)

Advisors’ Opinion:

  • [By Lisa Levin]

    Friday afternoon, the telecommunication services shares rose 2.1 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 11 percent, and Sify Technologies Limited (NASDAQ: SIFY) up 4 percent.

  • [By Money Morning Reports]

    Like Sify Technologies Ltd. (Nasdaq: SIFY)… a 143% winner… Fanhua Inc. (Nasdaq: FANH)… a 245.56% winner… and Boot Barn Holdings Inc. (NYSE: BOOT)… netting an astounding gain of 260%.

Top 10 Tech Stocks To Own Right Now: Shopify Inc.(SHOP)

Advisors’ Opinion:

  • [By Rick Munarriz]

    Shares of Shopify (NYSE:SHOP) hit all-time highs two weeks ago, but a swift correction finds the dot-com darling kicking off this new trading week 17% below those peak levels. The sell-off is creating a tempting buying opportunity for investors that have missed out on one of last year’s hottest stocks, but it’s always difficult to time an entry point in a stock that’s correcting. 

  • [By Sean Williams]

    A third stock that could see significant benefits from the marijuana industry, but that has a safety net built into its business model, is Shopify (NYSE:SHOP).

  • [By Steve Symington, Anders Bylund, and Rich Duprey]

    Shopify (NYSE:SHOP) stock has proven an overwhelming success for early investors, soaring more than fivefold since its IPO in mid-2015. And it’s not hard to make the case that the e-commerce platform company is only just getting started. 

  • [By Jon C. Ogg]

    Shopify Inc. (NYSE: SHOP) was up 1.4% at $175.55 on Tuesday in reaction to earnings and shares were indicated up another 2% at $179.00 on Wednesday. RBC Capital Markets upgraded it to Outperform from Sector Perform and raised the target price to $230 from $180. Wedbush Securities reiterated its Outperform rating and $200 price target, noting that Shopify is well positioned to keep gaining its share of e-commerce wallets over time and to capture more merchants across the entire spectrum of size from aspirational to established companies to enterprise level.

  • [By Leo Sun]

    Square’s plans with Weebly could also fall short of challenging Shopify (NYSE:SHOP), which leads the market in “digitizing” offline businesses. Shopify already helps businesses launch e-commerce platforms, design websites, process payments, launch marketing campaigns, handle deliveries, and more — so Square still has a lot of catching up to do.

  • [By Daniel Sparks]

    Amid the S&P 500’s nearly 5% gain over the past six months, one subsector has done exceptionally well: software-as-a-service (SaaS) stocks, particularly those providing platforms and applications to help businesses. The market seems head over heels for these stocks. Cloud-based customer relationship management company salesforce.com (NYSE:CRM), financial software company Intuit (NASDAQ:INTU), e-commerce platform Shopify (NYSE:SHOP), and payment processor Square (NYSE:SQ) have all soared 30% or more during the last six months alone.

Top 10 Tech Stocks To Own Right Now: Axcelis Technologies Inc.(ACLS)

Advisors’ Opinion:

  • [By ]

    3. Axcelis Technologies (Nasdaq: ACLS)
    It is the technical price pattern that first caught my eye with this $800 million market cap small cap.  Shares dropped to a $22.00 low in mid-February but have since been slowly and steadily moving higher toward resistance at both the 50- and 200-day SMAs. In and of itself, this is not enough impetus to get long. However, when combined with the fundamental picture, a compelling long thesis emerges.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Axcelis Technologies (ACLS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribing]

    Axcelis Technologies (NASDAQ:ACLS) Q4 2018 Earnings Conference CallFeb. 7, 2019 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Shares of Axcelis Technologies (NASDAQ:ACLS) have been assigned an average recommendation of “Buy” from the nine analysts that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $30.50.

  • [By Joseph Griffin]

    Alps Advisors Inc. raised its stake in shares of Axcelis Technologies Inc (NASDAQ:ACLS) by 13.4% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 20,773 shares of the semiconductor company’s stock after purchasing an additional 2,457 shares during the period. Alps Advisors Inc. owned approximately 0.06% of Axcelis Technologies worth $596,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Axcelis Technologies (ACLS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Tech Stocks To Own Right Now: Aerohive Networks, Inc.(HIVE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Here are some of the news articles that may have effected Accern’s rankings:

    Get Anthera Pharmaceuticals alerts:

    Cystic Fibrosis Drugs Market – Future Growth Prospects and Industry Trends Analyzed Till 2025 (digitaljournal.com) Analysts Anticipate Anthera Pharmaceuticals Inc (ANTH) Will Announce Earnings of -$0.60 Per Share (americanbankingnews.com) News Buzz : Blink Charging Co. (NASDAQ:BLNK), Genocea Biosciences, Inc. (NASDAQ:GNCA), Anthera … (journalfinance.net) Current Lumpy Stocks:: Jounce Therapeutics, Inc. (NASDAQ:JNCE), Aerohive Networks, Inc. (NYSE:HIVE), Anthera … (journalfinance.net) Porous, non-porous tantalum cups yielded similar septic, aseptic risks after revision THA (healio.com)

    ANTH has been the topic of a number of research analyst reports. Zacks Investment Research upgraded Anthera Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Tuesday, February 13th. Jefferies Financial Group reiterated a “hold” rating and set a $0.50 target price on shares of Anthera Pharmaceuticals in a research report on Thursday, March 15th. Roth Capital initiated coverage on Anthera Pharmaceuticals in a research report on Wednesday, February 21st. They set a “buy” rating and a $10.00 target price on the stock. Finally, Piper Jaffray Companies downgraded Anthera Pharmaceuticals from an “overweight” rating to an “underweight” rating in a research report on Monday, March 12th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $3.44.

  • [By Max Byerly]

    Leidos (NYSE: LDOS) and Aerohive Networks (NYSE:HIVE) are both aerospace companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

  • [By ]

    Our Biggest Loser… And A Bunch Of Big Wins
    Our biggest loser was back in January when we closed out of small communications equipment firm Aerohive Networks (Nasdaq: HIVE). On January 17, the company made a statement about its upcoming fourth-quarter earnings release, warning that revenue would likely be near the lower end of its guidance range. Investors didn’t take kindly to the news and sent shares tumbling by roughly 30%… well below our 15% trailing stop-loss. We ended up closing out with a 35% loss on the trade.

Top 10 Tech Stocks To Own Right Now: FormFactor, Inc.(FORM)

Advisors’ Opinion:

  • [By Motley Fool Transcription]

    FormFactor, Inc. (NASDAQ:FORM)Q4 2018 Earnings Conference CallFeb. 6, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    FormFactor, Inc. (NASDAQ:FORM) – Equities researchers at B. Riley dropped their FY2018 earnings per share (EPS) estimates for FormFactor in a research report issued to clients and investors on Monday, July 30th. B. Riley analyst C. Ellis now anticipates that the semiconductor company will post earnings of $0.74 per share for the year, down from their prior forecast of $0.98. B. Riley currently has a “Buy” rating and a $18.00 target price on the stock. B. Riley also issued estimates for FormFactor’s Q3 2019 earnings at $0.27 EPS, Q4 2019 earnings at $0.31 EPS and FY2019 earnings at $1.07 EPS.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
    Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
    Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
    FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
    Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
    National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
    United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
    Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
    athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
    Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
    Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
    Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
    AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
    CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
    Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
    LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on FormFactor (FORM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    SG Americas Securities LLC grew its position in FormFactor, Inc. (NASDAQ:FORM) by 237.1% in the second quarter, Holdings Channel reports. The fund owned 27,817 shares of the semiconductor company’s stock after buying an additional 19,565 shares during the period. SG Americas Securities LLC’s holdings in FormFactor were worth $370,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Stephan Byrd]

    FormFactor (NASDAQ:FORM) was downgraded by ValuEngine from a “hold” rating to a “sell” rating in a report released on Monday.

Top 10 Tech Stocks To Own Right Now: Lexmark International, Inc.(LXK)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Headlines about Lexmark International (NYSE:LXK) have trended somewhat positive on Sunday, Accern Sentiment reports. The research group scores the sentiment of media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Lexmark International earned a media sentiment score of 0.06 on Accern’s scale. Accern also assigned media coverage about the technology company an impact score of 42.803224128124 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Max Byerly]

    Press coverage about Lexmark International (NYSE:LXK) has been trending somewhat negative on Saturday, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Lexmark International earned a coverage optimism score of -0.10 on Accern’s scale. Accern also gave media coverage about the technology company an impact score of 42.9230217304115 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Top 5 Tech Stocks To Buy Right Now

Nandish Shah

HDFC Securities

The stock price of Mahindra CIE Automotive has broken out on the daily chart on Monday by closing above the resistance level of Rs 290 to close at 10-year high with higher volumes.

The momentum indicators and Oscillators like RSI and MACD have turned bullish on the daily and weekly charts. The stock has been trading above its 20, 50 and 200-DMA, indicating positional uptrend.

Therefore, we recommend buying Mahindra CIE for the upside target of Rs 325 and keeping a stop loss placed below Rs 285.

Disclaimer: The author is a Technical & Derivatives Analyst at HDFC Securities. The views and investment tips expressed by investment expert on moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Top 5 Tech Stocks To Buy Right Now: Bruker Corporation(BRKR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Here are some of the media stories that may have effected Accern’s rankings:

    Get Bruker alerts:

    Bruker Announces Improved Solutions for Microbial Strain Typing, Hospital Hygiene and Infection Control, and Candida auris Testing at ASM 2018 (finance.yahoo.com) Financial Review: Bruker (BRKR) versus Pacific Biosciences of California (PACB) (americanbankingnews.com) Global Microbiology Testing/Clinical Microbiology Market 2018-2024: Market is Influenced by Biomerieux, Abbott, Roche, Bruker and Bio-rad Labs (bizjournals.com) Bruker Corporation appoints Gerald Herman as CFO (seekingalpha.com) Bruker Corporation Appoints Gerald Herman as Chief Financial Officer (finance.yahoo.com)

    A number of brokerages have issued reports on BRKR. Zacks Investment Research cut Bruker from a “buy” rating to a “hold” rating in a research report on Friday. BTIG Research set a $42.00 target price on Bruker and gave the stock a “buy” rating in a research report on Sunday, May 6th. BidaskClub raised Bruker from a “hold” rating to a “buy” rating in a research report on Wednesday, May 23rd. Bank of America decreased their target price on Bruker from $37.00 to $34.00 and set a “neutral” rating for the company in a research report on Friday, May 4th. Finally, Leerink Swann upped their target price on Bruker from $32.00 to $34.00 and gave the stock a “market perform” rating in a research report on Friday, February 9th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $32.91.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Bruker (BRKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Bruker Corp  (NASDAQ:BRKR)Q4 2018 Earnings Conference CallFeb. 11, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Bruker (BRKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Bruker Co. (NASDAQ:BRKR) has received an average recommendation of “Hold” from the eleven brokerages that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $34.38.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Bruker (BRKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Tech Stocks To Buy Right Now: Aerohive Networks, Inc.(HIVE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Here are some of the news articles that may have effected Accern’s rankings:

    Get Anthera Pharmaceuticals alerts:

    Cystic Fibrosis Drugs Market – Future Growth Prospects and Industry Trends Analyzed Till 2025 (digitaljournal.com) Analysts Anticipate Anthera Pharmaceuticals Inc (ANTH) Will Announce Earnings of -$0.60 Per Share (americanbankingnews.com) News Buzz : Blink Charging Co. (NASDAQ:BLNK), Genocea Biosciences, Inc. (NASDAQ:GNCA), Anthera … (journalfinance.net) Current Lumpy Stocks:: Jounce Therapeutics, Inc. (NASDAQ:JNCE), Aerohive Networks, Inc. (NYSE:HIVE), Anthera … (journalfinance.net) Porous, non-porous tantalum cups yielded similar septic, aseptic risks after revision THA (healio.com)

    ANTH has been the topic of a number of research analyst reports. Zacks Investment Research upgraded Anthera Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Tuesday, February 13th. Jefferies Financial Group reiterated a “hold” rating and set a $0.50 target price on shares of Anthera Pharmaceuticals in a research report on Thursday, March 15th. Roth Capital initiated coverage on Anthera Pharmaceuticals in a research report on Wednesday, February 21st. They set a “buy” rating and a $10.00 target price on the stock. Finally, Piper Jaffray Companies downgraded Anthera Pharmaceuticals from an “overweight” rating to an “underweight” rating in a research report on Monday, March 12th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $3.44.

  • [By ]

    Our Biggest Loser… And A Bunch Of Big Wins
    Our biggest loser was back in January when we closed out of small communications equipment firm Aerohive Networks (Nasdaq: HIVE). On January 17, the company made a statement about its upcoming fourth-quarter earnings release, warning that revenue would likely be near the lower end of its guidance range. Investors didn’t take kindly to the news and sent shares tumbling by roughly 30%… well below our 15% trailing stop-loss. We ended up closing out with a 35% loss on the trade.

  • [By Logan Wallace]

    Aerohive Networks Inc (NYSE:HIVE) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 573,420 shares, a drop of 35.3% from the May 31st total of 885,671 shares. Based on an average trading volume of 381,201 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.8% of the shares of the stock are short sold.

  • [By Max Byerly]

    Leidos (NYSE: LDOS) and Aerohive Networks (NYSE:HIVE) are both aerospace companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

Top 5 Tech Stocks To Buy Right Now: Omnicell Inc.(OMCL)

Advisors’ Opinion:

  • [By Max Byerly]

    Legal & General Group Plc increased its stake in shares of Omnicell, Inc. (NASDAQ:OMCL) by 6.0% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 83,390 shares of the company’s stock after buying an additional 4,735 shares during the period. Legal & General Group Plc owned about 0.21% of Omnicell worth $4,378,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Omnicell, Inc. (NASDAQ:OMCL) shares hit a new 52-week high on Tuesday . The stock traded as high as $65.85 and last traded at $65.90, with a volume of 3793 shares traded. The stock had previously closed at $64.15.

  • [By Ethan Ryder]

    Omnicell Technologies (NASDAQ:OMCL) insider Peter J. Kuipers sold 724 shares of the company’s stock in a transaction dated Thursday, April 12th. The shares were sold at an average price of $46.00, for a total value of $33,304.00. Following the completion of the sale, the insider now directly owns 56,970 shares of the company’s stock, valued at $2,620,620. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

  • [By Stephan Byrd]

    Omnicell, Inc. (NASDAQ:OMCL) insider Peter J. Kuipers sold 9,144 shares of Omnicell stock in a transaction that occurred on Wednesday, June 6th. The shares were sold at an average price of $49.57, for a total transaction of $453,268.08. Following the completion of the sale, the insider now owns 56,970 shares of the company’s stock, valued at approximately $2,824,002.90. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Top 5 Tech Stocks To Buy Right Now: IPG Photonics Corporation(IPGP)

Advisors’ Opinion:

  • [By Rich Smith]

    Move over IPG Photonics (NASDAQ:IPGP). There’s a new laser maker in town — and Wall Street loves it.

    It’s been nearly a month now since tiny laser maker nLIGHT (NASDAQ:LASR) debuted on the Nasdaq. Up till now, the bankers who underwrote the IPO had been stuck in a “quiet period” in which they were unable to comment on the company’s prospects. Now, that quiet period has ended — and you can hardly shut them up about it.

  • [By Rich Smith]

    Shares of IPG Photonics (NASDAQ:IPGP) popped more than 10% in Tuesday morning trading, after the Oxford, Mass.-based fiber laser-maker reported mixed financial results for fiscal Q4  and full-year 2018.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss in the S&P 500 ahead of the close was IPG Photonics Corp. (NASDAQ: IPGP) which fell about 13.5% to $133.16. The stock’s 52-week range is $132.88 to $264.11. Volume was 3.7 million compared to the daily average volume of less than 1 million.

  • [By Anders Bylund]

    Shares of IPG Photonics (NASDAQ:IPGP) fell 11.1% in September, according to data from S&P Global Market Intelligence. The maker of fiber lasers and fiber amplifiers had nearly no news of its own last month, but the stock plunged anyway due to rumblings elsewhere in the fiber-optic equipment sector.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on IPG Photonics (IPGP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Tech Stocks To Buy Right Now: Illinois Tool Works Inc.(ITW)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Illinois Tool Works (ITW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    COPYRIGHT VIOLATION WARNING: “Guardian Investment Management Has $1.85 Million Holdings in Illinois Tool Works Inc. (ITW)” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at www.tickerreport.com/banking-finance/4151986/guardian-investment-management-has-1-85-million-holdings-in-illinois-tool-works-inc-itw.html.

  • [By ]

    Illinois Tools Works (ITW) shares fell after the company’s earnings report, but Cramer and the AAP team see it as an opportunity to buy more shares. Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Hot Tech Stocks To Invest In 2019

Brexit has some companies running scared. But not the tech industry.

Tech companies have announced a series of new investments in the United Kingdom even as major business groups warn that leaving the European Union could result in dire consequences.

The latest vote of confidence comes from US software titan Salesforce (CRM), which has committed to investing $2.5 billion over the next five years to help grow its business in the United Kingdom.

“Our commitment to driving growth, innovation and customer success in the region has never been stronger,” CEO Marc Benioff said in a statement.

Salesforce has plenty of company. Amazon (AMZN) announced last week that it would hire another 2,500 workers in the United Kingdom, bringing its total workforce in the country to over 27,500.

Mubadala, an investment company based in Abu Dhabi, announced this week that it would team up with Japan’s SoftBank (SFTBF) on a $400 million European tech fund based in London.

Hot Tech Stocks To Invest In 2019: NVIDIA Corporation(NVDA)

Advisors’ Opinion:

  • [By Harsh Chauhan]

    There’s a lot to like about NVIDIA (NASDAQ:NVDA). The graphics specialist has been clocking blistering growth quarter after quarter, thanks to solid demand for its chips across several verticals such as PC gaming, self-driving cars, virtual reality, and cloud computing. However, the company dividend is one area in which NVIDIA lacks big-time.

  • [By ]

    UBS also gave positive nods in the autonomous vehicle space to Nvidia (NVDA) and Intel (INTC) on the semi-conductor side of this growing business.

    Do I Get Long Google Now?

    I think I do, but as always, carefully. News broke last week that Amazon had halted the purchase of high revenue advertising space on Google search results. Alphabet’s stock did not even skip a beat. I would have liked to have seen some scattered weakness on this news, and I spent almost the entire day Monday bidding for these shares below the market, without ever really coming that close to buying any.

  • [By Beth McKenna]

    Shares of graphics chip specialist NVIDIA (NASDAQ:NVDA) have returned a mind-boggling 1,060% over the three-year period through Sept. 24, versus the broader market’s 60.7% return. The 10-year picture below is even prettier. 

  • [By Billy Duberstein]

    AMD has long been the only competitor to Intel (NASDAQ:INTC) in CPUs (central processing units), and Intel has long had a dominant near-monopoly on that market. AMD also makes GPUs (graphics processing units), where the company lags dominant GPU maker NVIDIA (NASDAQ:NVDA). As recently as just a few years ago, AMD was struggling with its technology roadmap, losing money every year from 2013 through 2016.

Hot Tech Stocks To Invest In 2019: Arris Group Inc(ARRS)

Advisors’ Opinion:

  • [By Max Byerly]

    Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) and ARRIS International (NASDAQ:ARRS) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

  • [By Lee Jackson]

    Jefferies sees this stock as another top value play in 2018. It has been a favorite at the firm for some time and remains a top small-cap pick. Arris International PLC (NASDAQ: ARRS) provides media entertainment and data communications solutions in the United States and internationally. It operates through two segments.

  • [By Max Byerly]

    Earnest Partners LLC increased its position in shares of ARRIS International plc (NASDAQ:ARRS) by 0.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 591,282 shares of the communications equipment provider’s stock after buying an additional 2,531 shares during the period. Earnest Partners LLC owned 0.32% of ARRIS International worth $15,710,000 as of its most recent filing with the SEC.

  • [By Max Byerly]

    Strs Ohio increased its stake in shares of ARRIS International plc (NASDAQ:ARRS) by 6.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,728,995 shares of the communications equipment provider’s stock after buying an additional 273,995 shares during the quarter. Strs Ohio owned about 2.54% of ARRIS International worth $115,600,000 at the end of the most recent quarter.

  • [By Max Byerly]

    LSV Asset Management lifted its stake in ARRIS International plc (NASDAQ:ARRS) by 178.4% in the second quarter, HoldingsChannel.com reports. The firm owned 101,897 shares of the communications equipment provider’s stock after buying an additional 65,297 shares during the period. LSV Asset Management’s holdings in ARRIS International were worth $2,490,000 at the end of the most recent quarter.

Hot Tech Stocks To Invest In 2019: Aerohive Networks, Inc.(HIVE)

Advisors’ Opinion:

  • [By ]

    Our Biggest Loser… And A Bunch Of Big Wins
    Our biggest loser was back in January when we closed out of small communications equipment firm Aerohive Networks (Nasdaq: HIVE). On January 17, the company made a statement about its upcoming fourth-quarter earnings release, warning that revenue would likely be near the lower end of its guidance range. Investors didn’t take kindly to the news and sent shares tumbling by roughly 30%… well below our 15% trailing stop-loss. We ended up closing out with a 35% loss on the trade.

  • [By Stephan Byrd]

    Here are some of the news articles that may have effected Accern’s rankings:

    Get Anthera Pharmaceuticals alerts:

    Cystic Fibrosis Drugs Market – Future Growth Prospects and Industry Trends Analyzed Till 2025 (digitaljournal.com) Analysts Anticipate Anthera Pharmaceuticals Inc (ANTH) Will Announce Earnings of -$0.60 Per Share (americanbankingnews.com) News Buzz : Blink Charging Co. (NASDAQ:BLNK), Genocea Biosciences, Inc. (NASDAQ:GNCA), Anthera … (journalfinance.net) Current Lumpy Stocks:: Jounce Therapeutics, Inc. (NASDAQ:JNCE), Aerohive Networks, Inc. (NYSE:HIVE), Anthera … (journalfinance.net) Porous, non-porous tantalum cups yielded similar septic, aseptic risks after revision THA (healio.com)

    ANTH has been the topic of a number of research analyst reports. Zacks Investment Research upgraded Anthera Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Tuesday, February 13th. Jefferies Financial Group reiterated a “hold” rating and set a $0.50 target price on shares of Anthera Pharmaceuticals in a research report on Thursday, March 15th. Roth Capital initiated coverage on Anthera Pharmaceuticals in a research report on Wednesday, February 21st. They set a “buy” rating and a $10.00 target price on the stock. Finally, Piper Jaffray Companies downgraded Anthera Pharmaceuticals from an “overweight” rating to an “underweight” rating in a research report on Monday, March 12th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $3.44.

  • [By Max Byerly]

    Leidos (NYSE: LDOS) and Aerohive Networks (NYSE:HIVE) are both aerospace companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

  • [By Logan Wallace]

    Aerohive Networks Inc (NYSE:HIVE) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 573,420 shares, a drop of 35.3% from the May 31st total of 885,671 shares. Based on an average trading volume of 381,201 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.8% of the shares of the stock are short sold.

Hot Tech Stocks To Invest In 2019: TeleNav Inc.(TNAV)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Telenav (TNAV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Telenav (NASDAQ:TNAV) from a sell rating to a hold rating in a research note published on Saturday.

    Several other equities research analysts also recently issued reports on TNAV. BidaskClub upgraded Telenav from a sell rating to a hold rating in a report on Friday. Zacks Investment Research upgraded Telenav from a sell rating to a hold rating in a report on Thursday, April 5th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock presently has an average rating of Buy and an average target price of $11.17.

  • [By Stephan Byrd]

    These are some of the media stories that may have effected Accern Sentiment Analysis’s scoring:

    Get Telenav alerts:

    Telenav, Inc. (TNAV) CEO HP Jin on Q4 2018 Results – Earnings Call Transcript (seekingalpha.com) Telenav EPS in-line, beats on revenue (seekingalpha.com) Telenav: Fiscal 4Q Earnings Snapshot (finance.yahoo.com) Telenav (TNAV) Reports Q4 Loss, Tops Revenue Estimates (finance.yahoo.com) Telenav (TNAV) Posts Earnings Results, Meets Estimates (americanbankingnews.com)

    TNAV has been the topic of a number of analyst reports. ValuEngine raised shares of Telenav from a “strong sell” rating to a “sell” rating in a research report on Saturday, June 2nd. B. Riley reaffirmed a “buy” rating on shares of Telenav in a research report on Monday, July 23rd. Finally, BidaskClub raised shares of Telenav from a “sell” rating to a “hold” rating in a research report on Wednesday, July 25th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $9.25.

Hot Tech Stocks To Invest In 2019: McGrath RentCorp(MGRC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    McGrath RentCorp (NASDAQ: MGRC) and Triton International (NYSE:TRTN) are both finance companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, risk, earnings, valuation and institutional ownership.

  • [By Ethan Ryder]

    McGrath RentCorp (NASDAQ:MGRC) VP Kay Dashner sold 1,993 shares of the company’s stock in a transaction on Friday, June 1st. The shares were sold at an average price of $65.30, for a total transaction of $130,142.90. Following the sale, the vice president now directly owns 4,891 shares in the company, valued at approximately $319,382.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Hot Tech Stocks To Invest In 2019: Pegasystems Inc.(PEGA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Corelogic (NASDAQ: PEGA) and Pegasystems (NASDAQ:PEGA) are both mid-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings and dividends.

  • [By Stephan Byrd]

    Pegasystems (NASDAQ:PEGA) was downgraded by BidaskClub from a “hold” rating to a “sell” rating in a report released on Wednesday.

  • [By Logan Wallace]

    Pegasystems (NASDAQ:PEGA) was upgraded by stock analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued on Friday.

Top 10 Stocks To Own Right Now

Virginia Retirement Systems ET AL acquired a new position in Olin Co. (NYSE:OLN) in the 1st quarter, HoldingsChannel reports. The firm acquired 11,800 shares of the specialty chemicals company’s stock, valued at approximately $359,000.

Several other institutional investors also recently modified their holdings of OLN. Bessemer Group Inc. raised its stake in shares of Olin by 971.4% in the fourth quarter. Bessemer Group Inc. now owns 4,725 shares of the specialty chemicals company’s stock worth $168,000 after purchasing an additional 4,284 shares during the last quarter. Fuller & Thaler Asset Management Inc. purchased a new stake in shares of Olin during the fourth quarter valued at approximately $178,000. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of Olin during the fourth quarter valued at approximately $201,000. Atria Investments LLC purchased a new stake in shares of Olin during the first quarter valued at approximately $201,000. Finally, Naples Global Advisors LLC purchased a new stake in shares of Olin during the fourth quarter valued at approximately $206,000. 89.02% of the stock is owned by hedge funds and other institutional investors.

Top 10 Stocks To Own Right Now: Aerohive Networks, Inc.(HIVE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Aerohive Networks Inc (NYSE:HIVE) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 573,420 shares, a drop of 35.3% from the May 31st total of 885,671 shares. Based on an average trading volume of 381,201 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.8% of the shares of the stock are short sold.

  • [By Max Byerly]

    Leidos (NYSE: LDOS) and Aerohive Networks (NYSE:HIVE) are both aerospace companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

  • [By Stephan Byrd]

    Here are some of the news articles that may have effected Accern’s rankings:

    Get Anthera Pharmaceuticals alerts:

    Cystic Fibrosis Drugs Market – Future Growth Prospects and Industry Trends Analyzed Till 2025 (digitaljournal.com) Analysts Anticipate Anthera Pharmaceuticals Inc (ANTH) Will Announce Earnings of -$0.60 Per Share (americanbankingnews.com) News Buzz : Blink Charging Co. (NASDAQ:BLNK), Genocea Biosciences, Inc. (NASDAQ:GNCA), Anthera … (journalfinance.net) Current Lumpy Stocks:: Jounce Therapeutics, Inc. (NASDAQ:JNCE), Aerohive Networks, Inc. (NYSE:HIVE), Anthera … (journalfinance.net) Porous, non-porous tantalum cups yielded similar septic, aseptic risks after revision THA (healio.com)

    ANTH has been the topic of a number of research analyst reports. Zacks Investment Research upgraded Anthera Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Tuesday, February 13th. Jefferies Financial Group reiterated a “hold” rating and set a $0.50 target price on shares of Anthera Pharmaceuticals in a research report on Thursday, March 15th. Roth Capital initiated coverage on Anthera Pharmaceuticals in a research report on Wednesday, February 21st. They set a “buy” rating and a $10.00 target price on the stock. Finally, Piper Jaffray Companies downgraded Anthera Pharmaceuticals from an “overweight” rating to an “underweight” rating in a research report on Monday, March 12th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $3.44.

Top 10 Stocks To Own Right Now: Tree.com Inc.(TREE)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market climbed sharply on Thursday, responding well to favorable earnings results from several corners of the market. Major benchmarks were up 1% to 2%, with particularly good performance from the Nasdaq Composite thanks to the tech sector’s outperformance during the day. Yet some stocks suffered from bad news that cast doubt on companies’ ability to benefit from generally favorable business conditions. MGM Resorts International (NYSE:MGM), Arch Coal (NYSE:ARCH), and LendingTree (NASDAQ:TREE) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Logan Wallace]

    Rhumbline Advisers decreased its position in LendingTree (NASDAQ:TREE) by 13.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,988 shares of the financial services provider’s stock after selling 2,252 shares during the period. Rhumbline Advisers’ holdings in LendingTree were worth $4,590,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Logan Wallace]

    Gabelli Funds LLC trimmed its position in shares of LendingTree (NASDAQ:TREE) by 2.9% during the first quarter, Holdings Channel reports. The institutional investor owned 8,450 shares of the financial services provider’s stock after selling 250 shares during the period. Gabelli Funds LLC’s holdings in LendingTree were worth $2,773,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    These are some of the media headlines that may have effected Accern’s rankings:

    Get LendingTree alerts:

    Zacks: Brokerages Expect LendingTree (TREE) to Post $1.24 EPS (americanbankingnews.com) Form 4/A LendingTree, Inc. For: Apr 12 Filed by: LEBDA DOUGLAS R (streetinsider.com) Form 4/A LendingTree, Inc. For: May 08 Filed by: LEBDA DOUGLAS R (streetinsider.com) LendingTree to acquire Ovation Credit for $20.75 million (wraltechwire.com) LendingTree to buy credit-service provider (mpamag.com)

    LendingTree opened at $271.05 on Wednesday, Marketbeat.com reports. The company has a market capitalization of $3.49 billion, a P/E ratio of 89.75, a price-to-earnings-growth ratio of 2.15 and a beta of 1.77. LendingTree has a 12-month low of $269.95 and a 12-month high of $278.10. The company has a current ratio of 3.33, a quick ratio of 3.33 and a debt-to-equity ratio of 0.73.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Lendingtree (TREE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Lendingtree (TREE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Own Right Now: Regeneron Pharmaceuticals, Inc.(REGN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Regeneron Pharmaceuticals Inc (NASDAQ:REGN) major shareholder Sanofi sold 121,601 shares of Regeneron Pharmaceuticals stock in a transaction dated Friday, June 8th. The stock was sold at an average price of $309.31, for a total value of $37,612,405.31. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

  • [By Cory Renauer]

    The tumor suppressor protein tries to cut out inserted genes, but most of the drugs these companies are developing take a relatively simple disruptive approach. Editas’ lead program, EDIT-101 for the treatment of Leber Congenital Amaurosis snips out a little section of DNA that allows a sight-related gene to be expressed normally, but it doesn’t add anything. Intellia and its partner Regeneron (NASDAQ:REGN) intend to disrupt the production of transthyretin by snipping out a section of DNA without replacing anything either.

  • [By Stephan Byrd]

    Aperio Group LLC boosted its stake in Regeneron (NASDAQ:REGN) by 5.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 26,287 shares of the biopharmaceutical company’s stock after buying an additional 1,330 shares during the period. Aperio Group LLC’s holdings in Regeneron were worth $9,052,000 as of its most recent SEC filing.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Friday was Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) which rose about 7.5% to $310.61. The stocks 52-week range is $281.89 to $543.55. Volume was 2.8 million compared to the daily average volume of nearly 1 million.

Top 10 Stocks To Own Right Now: Motorola Solutions, Inc.(MSI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Norinchukin Bank The boosted its stake in shares of Motorola Solutions Inc (NYSE:MSI) by 16.8% during the first quarter, HoldingsChannel.com reports. The firm owned 15,755 shares of the communications equipment provider’s stock after purchasing an additional 2,263 shares during the quarter. Norinchukin Bank The’s holdings in Motorola Solutions were worth $1,659,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Peter Graham]

    A long term performance chart shows Qualcomm breaking even whilepotential peers Cisco Systems, Inc (NASDAQ: CSCO) and Motorola Solutions Inc (NYSE: MSI) have performed better with theirheir share of volatility:

  • [By Shane Hupp]

    Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp lowered its holdings in Motorola Solutions Inc (NYSE:MSI) by 4.6% in the 1st quarter, HoldingsChannel.com reports. The firm owned 434,200 shares of the communications equipment provider’s stock after selling 20,800 shares during the quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp’s holdings in Motorola Solutions were worth $45,721,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Element Capital Management LLC acquired a new position in Motorola Solutions Inc (NYSE:MSI) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 98,736 shares of the communications equipment provider’s stock, valued at approximately $10,397,000.

  • [By Joseph Griffin]

    Morneau Shepell Inc (TSE:MSI) declared a monthly dividend on Tuesday, June 19th, Zacks reports. Investors of record on Friday, June 29th will be given a dividend of 0.065 per share on Monday, July 16th. This represents a $0.78 annualized dividend and a dividend yield of 2.85%. The ex-dividend date of this dividend is Thursday, June 28th.

Top 10 Stocks To Own Right Now: Invesco Credit Opportunities Fund(VTA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Headlines about Invesco Dynamic Credit Opportunities Fd (NYSE:VTA) have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Invesco Dynamic Credit Opportunities Fd earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned press coverage about the investment management company an impact score of 46.2340823797619 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Top 10 Stocks To Own Right Now: Chemical Financial Corporation(CHFC)

Advisors’ Opinion:

  • [By Max Byerly]

    Chemical Financial (NASDAQ: CHFC) and Macatawa Bank (NASDAQ:MCBC) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk.

  • [By Max Byerly]

    Envestnet Asset Management Inc. boosted its stake in Chemical Financial Co. (NASDAQ:CHFC) by 60.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,192 shares of the bank’s stock after purchasing an additional 6,123 shares during the period. Envestnet Asset Management Inc.’s holdings in Chemical Financial were worth $884,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Media stories about Chemical Financial (NASDAQ:CHFC) have been trending somewhat positive recently, Accern reports. Accern ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Chemical Financial earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned news articles about the bank an impact score of 45.6707430515367 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Stocks To Own Right Now: P.T. Telekomunikasi Indonesia Tbk.(TLK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday afternoon, the telecommunication services shares climbed 1.18 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 7 percent, and Telekomnks Indn Prsr Tbk Prshn Prsrn-ADR (NYSE: TLK), up 3 percent.

  • [By Anders Bylund]

    Telekomunikasi Indonesia (NYSE:TLK), the largest telecommunications company in Indonesia, reported first-quarter results on Tuesday, May 2. Top-line sales rose modestly in the first quarter thanks to higher wireless subscriber counts and a healthy broadband business, but those upsides had to overcome a substantial headwind from a mass exodus of old-school wireline subscribers.

  • [By Max Byerly]

    Telekomnks Indn Prsr Tbk Prshn Prsrn (NYSE:TLK) was upgraded by equities research analysts at Macquarie from a “neutral” rating to an “outperform” rating in a research report issued to clients and investors on Wednesday, The Fly reports.

Top 10 Stocks To Own Right Now: DBV Technologies S.A.(DBVT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on DBV Technologies (DBVT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Shares of DBV Technologies (NASDAQ:DBVT) have earned a consensus recommendation of “Hold” from the twelve research firms that are currently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $44.00.

  • [By Max Byerly]

    Shares of DBV Technologies (NASDAQ:DBVT) hit a new 52-week low on Tuesday . The stock traded as low as $20.00 and last traded at $20.31, with a volume of 2187 shares trading hands. The stock had previously closed at $20.07.

Top 10 Stocks To Own Right Now: First Cash Financial Services, Inc.(FCFS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    First Cash Financial Services (NYSE: FCFS) and Ferrellgas Partners (NYSE:FGP) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, valuation, earnings, risk, analyst recommendations and profitability.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on First Cash Financial Services (FCFS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    First Cash Financial Services, Inc. (NYSE:FCFS) shares hit a new 52-week high and low during trading on Thursday . The company traded as low as $88.95 and last traded at $88.70, with a volume of 371494 shares traded. The stock had previously closed at $87.80.

  • [By Shane Hupp]

    FirstCash (NYSE: FCFS) and CafePress (NASDAQ:PRSS) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends.

Top 10 Stocks To Own Right Now: United States Cellular Corporation(USM)

Advisors’ Opinion:

  • [By Logan Wallace]

    These are some of the media stories that may have impacted Accern Sentiment Analysis’s analysis:

    Get U.S. Cellular alerts:

    $962.41 Million in Sales Expected for U.S. Cellular (USM) This Quarter (americanbankingnews.com) $0.21 Earnings Per Share Expected for U.S. Cellular (USM) This Quarter (americanbankingnews.com) OneNeck IT Solutions named to CRNs 2018 Solution Provider 500 list (prweb.com) U.S. Cellular Unveils Offers on iPhones With New Connections (zacks.com)

    USM has been the subject of several research analyst reports. Raymond James raised shares of U.S. Cellular from a “market perform” rating to an “outperform” rating in a research report on Wednesday, May 2nd. ValuEngine raised shares of U.S. Cellular from a “sell” rating to a “hold” rating in a research report on Monday, April 2nd. Finally, Zacks Investment Research raised shares of U.S. Cellular from a “hold” rating to a “buy” rating and set a $41.00 price objective for the company in a research report on Tuesday, February 27th.

  • [By Ethan Ryder]

    NII (NASDAQ: NIHD) and U.S. Cellular (NYSE:USM) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, profitability and dividends.

  • [By Max Byerly]

    JPMorgan Chase & Co. raised its holdings in U.S. Cellular (NYSE:USM) by 770.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 52,229 shares of the Wireless communications provider’s stock after acquiring an additional 46,231 shares during the period. JPMorgan Chase & Co. owned about 0.06% of U.S. Cellular worth $2,099,000 at the end of the most recent quarter.

Hot Heal Care Stocks To Own For 2019

There are countless investing rules, mantras and cliches out there ranging from extremely useful to downright dangerous.

One of the most widely accepted and potentially detrimental to your portfolio is, “Buy low, sell high.”

When taken literally, of course, to make a profit you must sell a stock for more than you paid for it. But the essence of buy low, sell high has become one of the costliest myths on Wall Street.

Investors have been trained to think that “undervalued” stocks have the most upside potential. The problem is that this approach often causes investors to overlook the market’s best-performing stocks in favor of the ones doing the worst. Since underperforming investments usually sport lower valuations, investors tend to think these stocks are the more attractive buys.

Hot Heal Care Stocks To Own For 2019: Enerplus Corporation(ERF)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Enerplus (NYSE:ERF) (TSE:ERF) – Stock analysts at National Bank Financial reduced their FY2018 earnings estimates for Enerplus in a research note issued on Thursday, May 3rd. National Bank Financial analyst T. Wood now forecasts that the oil and natural gas company will earn $1.13 per share for the year, down from their previous estimate of $1.27. National Bank Financial also issued estimates for Enerplus’ FY2019 earnings at $1.96 EPS.

  • [By Max Byerly]

    Enerplus (TSE:ERF) (NYSE:ERF) had its target price hoisted by CIBC from C$19.00 to C$20.00 in a research note published on Friday morning.

    Other research analysts also recently issued research reports about the stock. CSFB upped their price objective on shares of Enerplus from C$17.00 to C$20.00 in a report on Friday, April 13th. GMP Securities upped their price objective on shares of Enerplus from C$17.00 to C$18.00 in a report on Thursday, March 1st. Barclays upped their price objective on shares of Enerplus from C$18.00 to C$20.00 in a report on Monday, February 26th. Canaccord Genuity upped their price objective on shares of Enerplus from C$16.50 to C$17.00 in a report on Monday, February 26th. Finally, Desjardins upped their price objective on shares of Enerplus from C$16.00 to C$17.50 in a report on Monday, February 26th. Seven equities research analysts have rated the stock with a buy rating, The stock has an average rating of Buy and an average price target of C$18.29.

Hot Heal Care Stocks To Own For 2019: Yingli Green Energy Holding Company Limited(YGE)

Advisors’ Opinion:

  • [By Logan Wallace]

    ValuEngine upgraded shares of Yingli (NYSE:YGE) from a sell rating to a hold rating in a report published on Saturday morning.

    Yingli stock opened at $1.60 on Friday. The company has a market capitalization of $30.36 million, a PE ratio of -0.17 and a beta of 1.98. Yingli has a twelve month low of $1.43 and a twelve month high of $2.86. The company has a quick ratio of 0.33, a current ratio of 0.40 and a debt-to-equity ratio of -0.11.

  • [By Joseph Griffin]

    Yingli Green Energy (NYSE:YGE) had its target price raised by S&P Equity Research from $0.45 to $0.62 in a research report released on Tuesday morning.

  • [By Joseph Griffin]

    Yingli Green Energy Holding Co Ltd (NYSE:YGE) shares reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $1.40 and last traded at $1.53, with a volume of 75280 shares. The stock had previously closed at $1.57.

  • [By Paul Ausick]

    Yingli Green Energy Holding Co. Ltd. (NYSE: YGE) slipped about 1.2% to post a new 52-week low of $1.68 Friday after closing at $1.70 on Thursday. The 52-week high is $3.35. Volume of about 5.9 million was more than 15 times the daily average of around 88,000. The company had no specific news.

Hot Heal Care Stocks To Own For 2019: Aerohive Networks, Inc.(HIVE)

Advisors’ Opinion:

  • [By Max Byerly]

    Leidos (NYSE: LDOS) and Aerohive Networks (NYSE:HIVE) are both aerospace companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

  • [By Logan Wallace]

    Aerohive Networks Inc (NYSE:HIVE) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 573,420 shares, a drop of 35.3% from the May 31st total of 885,671 shares. Based on an average trading volume of 381,201 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.8% of the shares of the stock are short sold.

  • [By Stephan Byrd]

    Here are some of the news articles that may have effected Accern’s rankings:

    Get Anthera Pharmaceuticals alerts:

    Cystic Fibrosis Drugs Market – Future Growth Prospects and Industry Trends Analyzed Till 2025 (digitaljournal.com) Analysts Anticipate Anthera Pharmaceuticals Inc (ANTH) Will Announce Earnings of -$0.60 Per Share (americanbankingnews.com) News Buzz : Blink Charging Co. (NASDAQ:BLNK), Genocea Biosciences, Inc. (NASDAQ:GNCA), Anthera … (journalfinance.net) Current Lumpy Stocks:: Jounce Therapeutics, Inc. (NASDAQ:JNCE), Aerohive Networks, Inc. (NYSE:HIVE), Anthera … (journalfinance.net) Porous, non-porous tantalum cups yielded similar septic, aseptic risks after revision THA (healio.com)

    ANTH has been the topic of a number of research analyst reports. Zacks Investment Research upgraded Anthera Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Tuesday, February 13th. Jefferies Financial Group reiterated a “hold” rating and set a $0.50 target price on shares of Anthera Pharmaceuticals in a research report on Thursday, March 15th. Roth Capital initiated coverage on Anthera Pharmaceuticals in a research report on Wednesday, February 21st. They set a “buy” rating and a $10.00 target price on the stock. Finally, Piper Jaffray Companies downgraded Anthera Pharmaceuticals from an “overweight” rating to an “underweight” rating in a research report on Monday, March 12th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $3.44.